Arrowstreet Capital, Limited Partnership Orasure Technologies Inc Transaction History

Arrowstreet Capital, Limited Partnership

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.08 - $8.28 $513,212 - $698,914	-84,410 Reduced 17.97%	385,190 $2.37 Million
Q4 2023 Feb 14, 2024	BUY	$5.13 - $8.35 $725,525 - $1.18 Million	141,428 Added 43.1%	469,600 $3.85 Million
Q3 2023 Nov 14, 2023	SELL	$4.4 - $6.91 $277 - $435	-63 Reduced 0.02%	328,172 $1.95 Million
Q2 2023 Aug 14, 2023	BUY	$4.88 - $7.39 $283,269 - $428,967	58,047 Added 21.48%	328,235 $1.64 Million
Q1 2023 May 15, 2023	BUY	$4.66 - $6.52 $1.26 Million - $1.76 Million	270,188 New	270,188 $1.64 Million
Q4 2018 Feb 14, 2019	SELL	$10.53 - $15.54 $301,874 - $445,500	-28,668 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$15.25 - $17.72 $6.44 Million - $7.48 Million	-422,280 Reduced 93.64%	28,668 $443,000
Q2 2018 Aug 14, 2018	SELL	$14.46 - $18.08 $1.11 Million - $1.39 Million	-76,647 Reduced 14.53%	450,948 $7.43 Million
Q1 2018 May 14, 2018	BUY	$16.77 - $22.04 $2.11 Million - $2.77 Million	125,523 Added 31.22%	527,595 $8.91 Million
Q4 2017 Feb 09, 2018	BUY	$13.44 - $22.81 $5.4 Million - $9.17 Million	402,072	402,072 $7.58 Million

225

68M

8.5K

11.8K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $312M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.